Perforation of the Nasal Septum and Nasal Ulcers

Maria Pilar Martín-Fortea, Isabel Sanjoaquín-Conde, Santiago Letona-Carbajo, Maria José Crusells-Canales, Julián Cuesta-Muñoz, Juan Antonio Amiguet-García

.

DOI: 10.4236/wja.2011.12005                

Abstract

A case about a HIV woman with nasal ulcers is described in this paper. In every inmunodepressed patient who has mu-cosal or cutaneous ulcers, infection by leishmanial parasites needs to be ruled out, especially when ulcers have not re-gression with usual treatments. The Leishmanial nasal disease usually shows swelling and mucosal ulcers, that may progress to necrosis. Delaying in appropriate therapy might cause irreversible damage.

Keywords

Mucocutaneous Leishmaniasis, Leishmania/HIV Co-Infection, Nasal Ulcer

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	M. M. Lessa, H. A. Lessa, T. W. Castro, A. Oliveira, A. Scherifer, et al., “Mucosal Leishmaniasis: Epidemo- logical and Clinical Aspects,” Revista Brasileira de Otorrinolaringologia, Vol. 73, No. 6, 2007, pp. 843-847. doi:10.1590/S0034-72992007000600016
[2]	E. Shwart, C. Hatz and J. Blum, “New World Cutaneous Leishmaniasis in Travellers,” Lancet Infectious Diseases, Vol. 6, No. 6, 2006, pp. 342-349. doi:10.1016/S1473-3099(06)70492-3
[3]	M. Mateo, I. Cruz, M. D. Flores and R. López-Vélez, “Slowly Progressing Skin Ulcers Following a Stay in Costa Rica,” Enfermedades Infecciosas y Microbiología Clínica, Vol. 23, No. 4, 2005, pp. 243-244. doi:10.1157/13073152
[4]	B. Herwaldt, “Leishmaniasis,” Lancet, Vol. 354, 1999, pp. 1191-1199. doi:10.1016/S0140-6736(98)10178-2
[5]	J. Alvar, J. A. Ballesteros, R. Soler, A. Beniro, G. J. van Eys, et al., “Mucocutaneous Leishmaniasis due to Leishmania (Leishmania) Infantum: Biochemical Characterization,” The American Journal of Tropical Medicine and Hygiene, Vol. 43, No. 6, 1990, pp. 614-618.
[6]	P. A. van Damme, M. Keuter, S. Van Assen, P. M. De-Wilde and P. J. A. Beckers, “A Rare Case of Oral Leishmaniasis,” Lancet Infectious Diseases, Vol. 4, No. 1, 2004, p. 53. doi:10.1016/S1473-3099(03)00861-2
[7]	J. M. Ramos, Z. Zubero and J. Ena, “Inmigración y VIH. Aproximación a las Enfermedades Parasitarias y Vira- les,”Enfermedades Infecciosas y Microbiología Clínica, Vol. 26, No. 3, 2008, pp. 42-53. doi:10.1157/13123266
[8]	M. Gallego and C. Riera, “Las Leishmaniasis Humanas. Control de Calidad de la Sociedad Espa?ola de Enfer- medades Infecciosas y Microbiología Clínica.” http://www.seimc.org/control/revi_Para/leish.htm. Consulted in June 6th, 2010.
[9]	M. Trimarchi, G. Gregorini, F. Facchetti, M. L. Morassi, C. Manfredini, R. Maroldi, et al., “Cocaine-Induced Midline Destructive Lesions: Clinical, Radiographic, Histopathologic, and Serologic Features and Their Differentiation from Wegener Granulomatosis,” Medicine, Vol. 80, No. 6, 2001, pp. 391-404. doi:10.1097/00005792-200111000-00005
[10]	C. B. Bonner and I. Y. Castillo, “Lesión Destructiva de la Línea Media Inducida por Cocaína: Comunicación de un Caso,” Anales de Otorrinolaringología Mexicana, Vol. 54, No. 1, 2009, pp. 32-35.
[11]	Centers for Disease Control & Prevention, “National Center for Infectious Diseases, Division of Parasitic Diseases,” Consulted in 19 September 2010. http://www.dpd.cdc.gov/dpdx/HTML/Leishmaniasis.htm.
[12]	J. Alvar, C. Ca?avete, B. Gutiérrez-Solar, M. Jiménez, F. Laguna, et al., “Leishmania and Human Immunodeficiency Vírus Coinfection: The Firts 10 Years,” Clinical Microbiology Reviews, Vol. 10, No. 2, 1997, pp. 298-319.
[13]	M. Ara, C. Mailo, G. Peon, A. Clavel, J. Cuesta, et al., “Visceral Leishmaniasis with Cutaneous Lesions in a Patient Infected with Human Immunodeficiency Virus,” The British Journal of Dermatology, Vol. 139, No. 1, 1998, pp. 114-117. doi:10.1046/j.1365-2133.1998.02326.x